Two Phase 3 trials presented at Europe's leading oncology conference show major survival gains: Roche's divarasib outperforms ...

Skaff was diagnosed with breast cancer. It marked the beginning of several rounds of chemotherapy followed by surgery. “I ...

GSK Plc (LON:GSK) said on Monday its immunotherapy Jemperli cleared tumours completely in 76% of patients with a certain type ...

TRUMBULL — At the end of every win, the Trumbull girls volleyball team passes an "Eddie the Eagle" statue to its player of ...

OncoHost, a technology company transforming the approach to predictive precision diagnostics for improved patient outcomes, today announced new research that was presented at the European Society for ...

An analysis of United States data reveals a broad shift away from overtreatment of low-risk prostate cancer. The analysis ...

A new report on cancer treatment highlights progress in treating small cell lung cancer, an aggressive form of the disease ...

An analysis of United States data reveals a broad shift away from overtreatment of low-risk prostate cancer. The analysis published by Wiley online in ...

A new DNA test could help doctors determine which men with prostate cancer need more aggressive treatment and which may be spared additional therapy, offering fresh hope of reducing the treatment ...

On October 23, 2026, the New England Journal of Medicine (NEJM) published a new Phase III trial regarding first-line ...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, ...

Expert and company perspectives on the role of amivantamab in advancing first-line treatment “Patients with recurrent or metastatic head and neck cancer continue to face a poor prognosis, highlighting ...